Defibrotide in the Human Endotoxemia Model - an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide

Trial Profile

Defibrotide in the Human Endotoxemia Model - an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 03 Apr 2017

At a glance

  • Drugs Defibrotide (Primary) ; Lipopolysaccharide (Primary)
  • Indications Diabetic nephropathies; Graft-versus-host disease; Veno-occlusive disorders
  • Focus Pharmacodynamics
  • Acronyms LPS_DF
  • Most Recent Events

    • 22 Mar 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2017.
    • 22 Mar 2017 Planned initiation date changed from 1 Sep 2016 to 1 Apr 2017.
    • 08 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top